Attached files
| file | filename |
|---|---|
| EX-3.1 - Arno Therapeutics, Inc | v201326_ex3-1.htm |
| EX-3.3 - Arno Therapeutics, Inc | v201326_ex3-3.htm |
| EX-4.5 - Arno Therapeutics, Inc | v201326_ex4-5.htm |
| EX-5.1 - Arno Therapeutics, Inc | v201326_ex5-1.htm |
| EX-4.3 - Arno Therapeutics, Inc | v201326_ex4-3.htm |
| EX-4.4 - Arno Therapeutics, Inc | v201326_ex4-4.htm |
| EX-23.2 - Arno Therapeutics, Inc | v201326_ex23-2.htm |
| EX-10.11 - Arno Therapeutics, Inc | v201326_ex10-11.htm |
| EX-10.13 - Arno Therapeutics, Inc | v201326_ex10-13.htm |
| EX-10.14 - Arno Therapeutics, Inc | v201326_ex10-14.htm |
| S-1 - Arno Therapeutics, Inc | v201326_s1.htm |
Exhibit
23.1
Consent
of Independent Registered Public Accounting Firm
We consent to the use in this
Registration Statement of Arno Therapeutics, Inc. on Form S-1 of our report
dated November 8, 2010, on the financial statements of Arno Therapeutics, Inc.
and to the reference to us under the heading “Experts” in the
prospectus.
/s/ Crowe
Horwath LLP
New York,
New York
November
8, 2010